YAP1 and metabolic dysfunction-associated steatohepatitis: Increased expression of YAP in RDCs has also been associated with the mRNA levels of pro-fibrogenic factors (Tgfβ1, Ctgf, and phospho-SMAD2) and proinflammatory factors (F4/80 and TNF-α) in mouse NASH [89].